December 12, 2017 11:51 AM ET

Biotechnology

Company Overview of Xenome Limited

Company Overview

Xenome Limited discovers and develops peptide-based therapeutics. It offers Xen2174, a conopeptide analogue, which is used for the treatment of cancer, post-operative, and chronic pain; and Kappa-opioid receptor and agonists that are used for the treatment of inflammatory pain. Xenome Limited was founded in 2000 and is based in Indooroopilly, Australia.

120 Meiers Road

Indooroopilly, QLD 4068

Australia

Founded in 2000

Phone:

61 7 3720 8055

Fax:

61 7 3720 8388

Key Executives for Xenome Limited

Chief Business Officer
Vice President of Strategic Marketing
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
AbRegen Pty Ltd. Asia
Advanced Wound Care Pty Ltd. Asia
Agriliance Pty Ltd. Asia
AION Diagnostics Limited Asia
Aquaceutics Pty Ltd Asia

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Xenome Limited, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.